The First International HPV Vaccine Information Clearinghouse
Case report
A 17-year-old female was referred for new-onset vision loss in both eyes 3 weeks after being vaccinated with the quadrivalent HPV vaccine. A standard dose of 0.5 ml was injected intramuscularly into the left deltoid without any resulting skin reaction. Her medical history was significant for depression treated with quetiapine. Three weeks following vaccination, she developed painless vision loss in the left eye …
Gaia-Health
The following pages contain three tables with the same data presented, differing only in terms of how it’s ordered.
Table 1 lists countries alphabetically.
Table 2 lists countries in order of recommended or mandated vaccinations for children under age 5.
Table 3 lists countries in order of mortality rates
of children under age 5.
_____________________
Note: All vaccine schedules are as of 2006. Some countries use combination vaccines. All schedule counts have been normalized to compare to the US schedule. For example, if a country uses an MMR-Varicella combination vaccine, it counts as 2 vaccines.
Australian Doctor
16 November 2005
An unglamorous quest to discover why HIV-positive men were plagued with anal warts led Professor Ian Frazer to a hugely lauded scientific discovery — a vaccine against cervical cancer. By Bianca Nogrady.
PROFESSOR Ian Frazer radiates energy, albeit an energy tinged with impatience. He may be enthusiastic and talkative throughout this umpteenth media interview, but you can tell he really just wants to get back to his work.
That’s understandable — after all, not only has he led research that could eliminate the spectre of cervical cancer, but he is now on the verge of another breakthrough that has some touting him as Australia’s next Nobel laureate.
Described as “the common cold of sexual activity”, HPV infects an estimated 630 million women around the world, indirectly claiming the lives of about 288,000 each year.
J Epidemiol Community Health
February 2010 Vol 64 No 2
For approximately 2 years now, cervical cancer has been “converted” from an oncological disease to an infectious disease, which is said to be preventable by and large by two vaccines licensed in many countries. However, human papillomavirus (HPV) vaccines differ from existing others, as the former target
a condition which only in a minute fraction of infections will lead to serious consequences, but after a long(er) latency period. Furthermore, it should be kept in mind that in clinical trials, the quadrivalent vaccine was tested in fewer than 1200 girls 16 years and younger.1
Prevent Disease
A shocking report from the National Coalition of Organized Women (NCOW) presented data from two different sources demonstrating that the 2009/10 H1N1 vaccines contributed to an estimated 1,588 miscarriages and stillbirths. A corrected estimate may be as high as 3,587 cases. NCOW also highlights the fact that the CDC failed to inform their vaccine providers of the incoming data of the reports of suspected H1N1 vaccine related fetal demise. NCOW collected the data from pregnant women (aged 17 to 45) that occurred after they were administered a 2009 A-H1N1 flu vaccine.The raw data is available on the ProgressiveConvergence.com website
Using the Vaccine Adverse Event Reporting System (VAERS), including updates through July 11, 2010 as a second ascertainment source, capture-recapture statistical methods were used to estimate the true number of miscarriages and stillbirths following A-H1N1 flu vaccination in the U.S.
